Abstract

Introduction: South Africa has an appreciable burden of both communicable and non-communicable diseases as well as high maternal, neonatal, and child morbidity. In recent years there have been significant strides with improving the public health system, and addressing current inequalities, with the right to health a constitutional provision in South Africa. Initiatives include the introduction of National Health Insurance, programmes to enhance access to medicines for patients with chronic diseases, as well as activities to improve care in hospitals, including improving pharmacovigilance. Consequently, the objective of this paper is to review ongoing initiatives within the public healthcare sector in South Africa and their influence to provide future direction.Method: Principally a structured review of current and planned activities.Results: There have been a number of major activities and initiatives surrounding the availability and access to medicines in the public system in recent years in South Africa. This includes a National Surveillance Centre and an innovative early warning system for the supply of medicines as well as the development of a National Health Care Pricing Authority and initiatives to improve contracting. There have also been developments to improve the supply chain including instigating Medicine Procurement Units in the provinces and enhancing forecasting capabilities. Access to medicines is improving though the instigation of stable chronic disease management initiatives to increase the number of external pick-up points for medicines. There are also ongoing programmes to enhance adherence to medicines as well as enhance adherence to the Standard Treatment Guidelines and the Essential Medicines List with their increasing availability. In addition, there is a movement to enhance the role of health technology assessment in future decision making. Hospital initiatives include increased focus on reducing antimicrobial resistance through instigating stewardship programmes as well as improving adverse drug reaction reporting and associated activities.Conclusion: Overall, there are an appreciable number of ongoing activities within the public healthcare system in South Africa attempting to ensure and sustain universal healthcare. It is too early to assess their impact, which will be the subject of future research.

Highlights

  • South Africa has an appreciable burden of both communicable and non-communicable diseases as well as high maternal, neonatal, and child morbidity

  • South Africa has extended the share of gross domestic product (GDP) devoted to health over the past two decades

  • In 1995, 7.42% of GDP was spent on health, whilst currently South Africa spends 8.5–8.9% of its GDP on health (Department of Health, 2015; Jakovljevic et al, 2017), with pharmaceuticals an estimated 10–15% of this

Read more

Summary

Introduction

South Africa has an appreciable burden of both communicable and non-communicable diseases as well as high maternal, neonatal, and child morbidity. As the right to health is a constitutional provision in South Africa, there has been a strive towards universal health coverage (UHC) and a unified health system to improve equitable access to medicines to the population as a whole (Department of Health, 2012, 2015; Sekhejane, 2013; Jakovljevic et al, 2017; Perumal-Pillay and Suleman, 2017a,b). South Africa is considered the flagship national health system in sub-Saharan Africa (Jakovljevic et al, 2017), with its National Department of Health (NDoH) moving towards UHC with the introduction of the National Health Insurance (NHI) initiative (Department of Health, 2015; Perumal-Pillay and Suleman, 2017a). This is likely to continue, certainly in the short to medium term

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call